|
Volumn 2, Issue 36, 2010, Pages
|
Stopping sepsis by targeting sphingosine kinase 1
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
COMPLEMENT COMPONENT C5;
ERITORAN;
I KAPPA B KINASE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PHOSPHOTRANSFERASE INHIBITOR;
PROTEIN KINASE C DELTA;
SMALL INTERFERING RNA;
SPHINGOSINE 1 PHOSPHATE;
SPHINGOSINE KINASE 1;
TOLL LIKE RECEPTOR 2;
TOLL LIKE RECEPTOR 4;
ENZYME INHIBITOR;
PHOSPHOTRANSFERASE;
SPHINGOSINE KINASE;
CYTOKINE PRODUCTION;
DRUG MECHANISM;
ENZYME PHOSPHORYLATION;
GENE EXPRESSION REGULATION;
GRAM NEGATIVE SEPSIS;
HUMAN;
IN VIVO STUDY;
INFECTION CONTROL;
LETHALITY;
MACROPHAGE MIGRATION INHIBITION;
NEUTROPHIL CHEMOTAXIS;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN TARGETING;
REVIEW;
SEPSIS;
SEPTIC SHOCK;
SIGNAL TRANSDUCTION;
UPREGULATION;
VALIDATION PROCESS;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
METABOLISM;
ENZYME INHIBITORS;
HUMANS;
PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);
SEPSIS;
SIGNAL TRANSDUCTION;
|
EID: 77955631166
PISSN: 19466234
EISSN: 19466242
Source Type: Journal
DOI: 10.1126/scitranslmed.3001299 Document Type: Review |
Times cited : (4)
|
References (4)
|